FDAClass IRecall started December 15, 2025

MR. 7 Super Recall

MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7

What is the FDA recall status?

The FDA record lists this recall as ongoing. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions and check the agency notice or firm for current guidance.

How FDA enforcement data reports status

Why was MR. 7 Super recalled?

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil

What should I do if I have this product?

Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.

Full product description

MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7

Which lot codes, UPCs or models are affected?

All codes; Exp 12/31/2029

Agency record number
D-0397-2026
Product
MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7
Recalling firm
StuffbyNainax
Quantity
4
Distribution
Product was distributed to 4 customers in the US.
Recall started
December 15, 2025
Report date
March 11, 2026
Classification
Class I
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls